Research Units | Job Offer | Job Search | Personnel support areas


MARTINO Gianvito Tel.: +39 (02) 2643 4853 (4854/4867)

Fax: +39 (02) 2643 4855

e-mail: g.martino@hsr.it

 

Address

Neuroimmunology Unit

Dept. of Neuroscience
San Raffaele Scientific Institute
DIBIT, Via Olgettina 58
20132 Milan, ITALY

Research themes

Role of inflammatory mediators (cytokines, chemokines, cystein proteases) and T cells in immune-mediated diseases of the central nervous system (CNS) and neuromuscular diseases; development of gene-therapy approaches for demyelinating diseases (cytokine-based and neuroprotective treatments)

Key words

Inflammatory mediators (cytokines, chemokines, cystein proteases), T cells, viral vectors, gene-therapy, demyelination, remyelination, trophic factors, tumors, EAE, EAMG

Methods

Cell cultures (bulk, primary, organotypic, lines), cellular immunology (T cell proliferation and cytotoxic assays, FACS analysis), molecular biology (Southern and Northern blotting, recombinant DNA techniques), cytokine detection systems (ELISA, ICS, TaqmanÆ, ISH), chemokine and chemokine receptor detection systems (TaqmanÆ), immunocytochemistry, animal handling and manipulation (stereotaxis, EAE, EAMG, microsurgery)

Composition of the research group

Alessandra BERGAMI

Lab Technician

San Raffaele Scientific Institute

Elena BRAMBILLA

BS, Biologist

San Raffaele Scientific Institute

Roberto FURLAN

MD, PhD

San Raffaele Scientific Institute

Maira GIRONI

MD, Neurologist

San Raffaele Scientific Institute

Gianvito MARTINO

MD, Neurologist

San Raffaele Scientific Institute

Stefano PLUCHINO

MD, PhD Student

San Raffaele Scientific Institute

Francesca RUFFINI

BS, Biologist

San Raffaele Scientific Institute

Recent publications

  1. Cortese I, Tafi R, Grimaldi LME, Martino G, Nicosia A, Cortese R (1996) Identification of peptides specific for cerebrospinal fluid antibodies in multiple sclerosis by using phage libraries. Proc. Natl. Acad. Sci. USA, 93:11063-11067.
  2. Martino G, Grohovaz F, Brambilla E, Codazzi F, Consiglio A, Clementi E, Filippi M, Comi G, Grimaldi LME (1998) Proinflammatory cytokines regulate antigen-independent T-cell activation by two separate calcium-signaling pathways in multiple sclerosis patients. Ann. Neurol., 43:340-349.
  3. Filippi M, Rocca MA, Martino G, Horsfield MA, Comi G (1998) Magnetization transfer changes in the normal-appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann. Neurol., 43:809-814.
  4. Moiola L, Galbiati F, Martino G, Amadio S, Brambilla E, Comi G, Vincent A, Grimaldi LME, Adorini L (1998) IL-12 is required for the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease. Eur. J. Immunol., 28:2487-2497.
  5. Furlan R, Poliani PL, Galbiati F, Bergami A, Grimaldi LME, Comi G, Adorini L, Martino G (1998) Central nervous system delivery of interleukin-4 by a non-replicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination. Hum. Gene Ther., 9:2605-2617.
  6. Martino G, Hartung HP (1999) Immunopathogenesis of multiple sclerosis: the role of T cells. Curr. Opin. Neurol., 12:309-321.
  7. Furlan R, Martino G, Galbiati F, Poliani PL, Smiroldo S, Bergami A, Desina G, Comi G, Flavell R, Su M, Adorini L (1999) Caspase-1 regulates the inflammatory process leading to autoimmune demyelination. J. Immunol., 163:2403-2409.
  8. Del Maschio A, De Luigi A, Martin-Padura I, Brockhaus M, Bartfai T, Fruscella P, Adorini L, Martino G, Furlan R, De Simoni MG, Dejana E (1999) Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM). J. Exp. Med., 190:1351-1356.
  9. Mattner F, Smiroldo S, Galbiati F, Muller M, Di Lucia P, Poliani PL, Martino G, Panina-Bordignon P, Adorini L (2000) Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin. Eur. J. Immunol., 30:498-508.
  10. Martino G, Poliani Pl, Marconi P, Comi G, Furlan R (2000) Cytokine gene therapy of autoimmune demyelination revisited using herpes simplex virus type-1-derived vectors. Gene Ther., 7:1087-1093.
  11. Martino G, Furlan R, Brambilla E., Bergami A., Ruffini F, Gironi M, Poliani PL, Grimaldi LME, Comi G (2000) Cytokines and Immunity in Multiple Sclerosis: the Dual Signal Hypothesis. J. Neuroimmunol., 109:3-9.
  12. Furlan R, Bergami A, Lang R, Brambilla E, Franciotta D, Martinelli V, Comi G, Panina P, Martino G (2000) Interferon-b treatment in multiple sclerosis patients decreases the number of circulating cells producing IFN-g and IL-4. J. Neuroimmunol., 111:86-92.
  13. FURLAN R, POLIANI PL, MARCONI PC, BERGAMI A, RUFFINI F, ADORINI L, GLORIOSO JC, COMI G, MARTINO G (2001) Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice. Gene Ther., 8:13-19.
  14. FRANCIOTTA DM, MARTINO G, ZARDINI E, FURLAN R, BERGAMASCHI R, ANDREONI L, COSI V (2001) Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies. J. Neuroimmunol., 115:192-198.
  15. POLIANI PL, BROK H, FURLAN R, RUFFINI F, BERGAMI A, DESINA G, MARCONI PC, ROVARIS M, UCCELLI A, GLORIOSO JC, PENNA G, ADORINI L, COMI G, t'HART B, MARTINO G (2001) Delivery of a non-replicative herpes simplex type-1 vector engineered with the IL-4 gene to the central nervous system protects rhesus monkeys from hyperacute autoimmune encephalomyelitis. Hum Gene Ther., 12:905-920.
  16. FURLAN R, BRAMBILLA E, RUFFINI F, POLIANI PL, BERGAMI A, MARCONI PC, FRANCIOTTA DM, PENNA G, COMI G, ADORINI L, MARTINO G (2001) Intrathecal delivery of IFNg protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of CNS-infiltrating lymphocytes. J Immunol., 167:1821-1829.
  17. MARTINO G, FURLAN R, COMI G, ADORINI L (2001) The ependymal route to the CNS: an emerging gene therapy approch for MS. Trends Immunol., 22:483-490.
  18. RUFFINI F, FURLAN R, POLIANI PL, BRAMBILLA E, MARCONI PC, BERGAMI A, DESINA G, GLORIOSO JC, COMI G, MARTINO G (2001) Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice. Gene Ther., 8:1207-1213.